JPRN-UMIN000025742招募中3 期
A phase III trial to confirm S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patients who underwent gastric resection (JCOG1507, BIRDIE) - A phase III trial to confirm S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patients who underwent gastric resection (JCOG1507, BIRDIE)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 370 人开始时间: 2017年1月19日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 370
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 80years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous double/multiple cancer or metachronous double/multiple cancer with progression free period of 5 years or shorter 2) Infectious disease requiring systemic treatment 3) Body temperature of 38 degrees Celsius or higher 4) Severe mental disease 5) Requiring systemic steroid medication (>= 5 mg/day of prednisolone) 6) Under treatment by flucytosine, phenytoin, or warfarin potassium 7) Uncontrolled diabetes mellitus 8) Uncontrolled hypertension 9) Unstable angina pectoris (angina developed or attack worsened within recent 3 weeks) or previous myocardial infarction within 6 months 10) Positive for HBs antigen 11) Severe interstitial pneumonia, severe lung fibrosis, or severe emphysema 12) Surgical morbidity such as infection, leakage, intestinal bleeding, pancreatic fistula, and so on is not improved
研究者
相似试验
已完成
3 期
Randomized phase III trial comparing adjuvant S-1 to capecitabine in stage III colorectal cancer (JCOG0910, CRC Adj-CAPS)Stage III colorectal cancerJPRN-UMIN000003272Japan Clinical Oncology Group(JCOG)1,550
招募中
3 期
JCOG1507: A phase III trial to confirm S-1 adjuvant chemotherapy for pathological stage II/III vulnerable elderly gastric cancer patientsGastric neoplasmJPRN-jRCTs031180255YOSHIDA Kazuhiro170
进行中（未招募）
1 期
Study of chemotherapy vs immunotherapy for patients with lung cancer bounded inthe thorax and completely resectedResectable Non-small cell lung cancerMedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104MedDRA version: 20.0Level: SOCClassification code: 10029104Term: Neoplasms benign malignant and unspecified (incl cysts and polyps) Class: 2CTIS2024-513730-38-00Fundacion GECP210
已完成
2 期
Phase II trial of S-1 monotherapy as adjuvant chemotherapy in triple negative breast cancer patients who did not achieve pathological complete response after neoadjuvant chemotherapyBreast cancerJPRN-UMIN000004340Kitasato University School of Medicine30
已完成
不适用
Randamised phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resectable bile duct cancerJPRN-UMIN000000820agoya Surgery Support Organization300